Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash from Investing Activities (2018 - 2025)

Historic Cash from Investing Activities for Organogenesis Holdings (ORGO) over the last 8 years, with Q3 2025 value amounting to -$2.2 million.

  • Organogenesis Holdings' Cash from Investing Activities rose 1300.12% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.9 million, marking a year-over-year decrease of 2866.43%. This contributed to the annual value of -$10.0 million for FY2024, which is 5882.45% up from last year.
  • Per Organogenesis Holdings' latest filing, its Cash from Investing Activities stood at -$2.2 million for Q3 2025, which was up 1300.12% from -$3.6 million recorded in Q2 2025.
  • Organogenesis Holdings' Cash from Investing Activities' 5-year high stood at -$1.9 million during Q2 2024, with a 5-year trough of -$16.7 million in Q3 2021.
  • Over the past 5 years, Organogenesis Holdings' median Cash from Investing Activities value was -$5.0 million (recorded in 2021), while the average stood at -$5.7 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first plummeted by 13109.33% in 2021, then soared by 7493.0% in 2024.
  • Organogenesis Holdings' Cash from Investing Activities (Quarter) stood at -$5.2 million in 2021, then plummeted by 103.86% to -$10.7 million in 2022, then skyrocketed by 68.81% to -$3.3 million in 2023, then fell by 1.11% to -$3.4 million in 2024, then surged by 33.5% to -$2.2 million in 2025.
  • Its last three reported values are -$2.2 million in Q3 2025, -$3.6 million for Q2 2025, and -$3.6 million during Q1 2025.